Impact of Paramedical Consultations in Oncological Supportive Care in Outpatients With Multiple Myeloma

Overview

Multiple myeloma is the second most frequent hematologic malignancy, which incidence augmented between 1995 and 2018, with an annual mean variation of +0.6% to 1.1%. Although treatment improved in the last years, the patients' prognostic is associated with cytogenetic abnormalities. Oncological supportive care provides patients with a global perspective, in addition to specific medical treatment adapted to pathology and patient profile. It contributes to the improvement of quality of life of patients, throughout their care pathway regarding physical, psychological and social aspects, according to their specific needs as well as their caregivers'. The aim of this study is to evaluate the quality of life at 6 months after multiple myeloma diagnosis in outpatients receiving paramedical consultations in oncological supportive care from the diagnosis versus outpatients receiving paramedical consultations in oncological supportive care after 6 months after diagnosis.

Full Title of Study: “Impact of Point in Time of Introducing Paramedical Consultations in Oncological Supportive Care in Outpatients With Multiple Myeloma”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Parallel Assignment
    • Primary Purpose: Supportive Care
    • Masking: None (Open Label)
  • Study Primary Completion Date: October 29, 2024

Interventions

  • Other: Early oncological supportive care
    • Several appointments (at diagnosis, 3 months, 6 months and 9 months) with nursing coordinator to define the needs in oncological supportive care. Different appointments will be planned according to patient’s needs, with several possibilities: oncological supportive care nurse, social worker, psychologist, physiotherapist, adapted physical activity, medication reconciliation, oncologic geriatric medicine, dietician, nutritionist, smoking cessation advisor, sexologist, sophrologist, pain management nursing and palliative care, socio-aesthetician and religious cult coordinator.
  • Other: Delayed oncological supportive care
    • Two appointments (6 months and 9 months) with nursing coordinator to define the needs in oncological supportive care. Different appointments will be planned according to patient’s needs, with several possibilities: oncological supportive care nurse, social worker, psychologist, physiotherapist, adapted physical activity, medication reconciliation, oncologic geriatric medicine, dietician, nutritionist, smoking cessation advisor, sexologist, sophrologist, pain management nursing and palliative care, socio-aesthetician and religious cult coordinator.

Arms, Groups and Cohorts

  • Experimental: Early oncological supportive care
    • Evaluation of needs in oncological supportive care by a nursing coordinator from diagnosis and recommendation to plan appointments with different specialists in supportive care regarding to patient’s needs
  • Other: Delayed oncological supportive care
    • Evaluation of needs in oncological supportive care by a nursing coordinator at 6 months after diagnosis and recommendation to plan appointments with different specialists in supportive care regarding to patient’s needs

Clinical Trial Outcome Measures

Primary Measures

  • Comparison of quality of life evolution in outpatients with multiple myeloma between the two groups
    • Time Frame: 6 months
    • Comparison of the score obtained with Functional Assessment of Cancer Therapy- Multiple Myeloma questionnary

Secondary Measures

  • Qualitative evaluation of quality of life
    • Time Frame: 6 months
    • Semi-structured individual interviews
  • Comparison of quality of life in outpatients with multiple myeloma between the two groups
    • Time Frame: 3 months
    • Comparison of the score obtained with Functional Assessment of Cancer Therapy- Multiple Myeloma questionnary
  • Comparison of quality of life in outpatients with multiple myeloma between the two groups
    • Time Frame: 9 months
    • Comparison of the score obtained with Functional Assessment of Cancer Therapy- Multiple Myeloma questionnary
  • Comparison of autonomy evolution in outpatients with multiple myeloma between the two groups
    • Time Frame: 6 months
    • Comparison of the score of Instrument Activities of daily Living questionnary

Participating in This Clinical Trial

Inclusion Criteria

  • Age superior to 18 years old – Patient recently diagnosed with multiple myeloma not eligible to autologous blood stem-cell transplantation, before starting therapy in day hospital – Patient coming regularly to Centre Henri Becquerel for treatment and follow up for multiple myeloma – Informed consent form signed Exclusion Criteria:

Inclusion Criteria:

  • Age superior to 18 years old – Patient recently diagnosed with multiple myeloma not eligible to autologous blood stem-cell transplantation, before starting therapy in day hospital – Patient coming regularly to Centre Henri Becquerel for treatment and follow up for multiple myeloma – Informed consent form signed Exclusion Criteria:

  • Patient with urgent need of treatment after multiple myeloma diagnosis with urgent and absolute need of oncological supportive care immediately after diagnosis – Patient deprived of liberty, under judicial supervision, under guardianship or trusteeship – History of psychological or sensorial disorder or anomaly that can prevent the patient from understanding the conditions for study participation

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Centre Henri Becquerel
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Official(s)
    • Amel Benchemam, Principal Investigator, Centre Henri Becquerel
  • Overall Contact(s)
    • Amel Benchemam, +332 32 08 29 20, amel.benchemam@chb.unicancer.fr

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.